News
Biosimilars promise cost savings and improved patient access in Latin America, yet face significant regulatory and ...
Number 5: Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, supports biosimilars for cost savings but foresees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback